Study of Fatty Acid Binding Protein 4 (FABP4) levels in Patients with Beta-thalassemia and its Related Complications... | ||||
| Fayoum University Medical Journal | ||||
| Volume 13, Issue 2, April 2024, Page 42-48 PDF (272.89 K) | ||||
| Document Type: Full Length research Papers | ||||
| DOI: 10.21608/fumj.2024.258395.1301 | ||||
 View on SCiNiTO | ||||
| Author | ||||
Basma Atiya Mohamed 
| ||||
| Internal Medicine, Faculty of Medicine, Fayoum University | ||||
| Abstract | ||||
| Abstract Introduction: Due to iron overload, patients with beta-thalassemia may experience complications. Several adipokines have been proposed as potential contributors to the development of beta-thalassemia complications. One of the adipokines, fatty acid-binding protein 4 (FABP4), connects various elements of the inflammatory and metabolic pathways. Aim of the study: This study assessed B-thalassemia patients' serum (FABP4) levels and linked them to complications related to thalassemia. Subjects and Methods: There were fifty adult participants in this cross-sectional study. A thorough clinical examination and medical history were completed. Every participant had their serum levels of fatty acid binding protein four measured. Results: According to our findings, 24% of patients had HCV +ve, 36% had gall bladder stones, and 44% had elevated liver enzymes. Patients with serum ferritin levels greater than 2500 ng/ml and FABP4 level did not significantly correlate (p value < 0.05). Conclusions: Patients with beta thalassemia had elevated liver enzymes, GB stones, and a high prevalence of HCV +ve. There was no discernible relationship between patients with serum ferritin levels higher than 2500 ng/ml and FABP4 level. Keywords: FABP4, beta-thalassemia, complications. | ||||
| Keywords | ||||
| FABP4; beta-thalassemia; complications | ||||
|
Statistics Article View: 18 PDF Download: 31 |
||||
